Related references
Note: Only part of the references are listed.MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
Katrina V. Good et al.
FRONTIERS IN GENETICS (2021)
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Shervin Pejhan et al.
BIOMOLECULES (2021)
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2021)
Metformin Protects against NMDA-Induced Retinal Injury through the MEK/ERK Signaling Pathway in Rats
Koki Watanabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Simvastatin Prevents Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease via Inhibition of A1 Reactive Astrocytes
Ren-Wei Du et al.
NEUROIMMUNOMODULATION (2021)
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
Osman Sharifi et al.
FRONTIERS IN GENETICS (2021)
Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
Cynthia Calkin et al.
FRONTIERS IN PSYCHIATRY (2021)
Chronic Ethanol Exposure Alters DNA Methylation in Neural Stem Cells: Role of Mouse Strain and Sex
Shayan Amiri et al.
MOLECULAR NEUROBIOLOGY (2020)
Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice
Yann Ehinger et al.
EMBO MOLECULAR MEDICINE (2020)
Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation
S. Pejhan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling
Catarina Miranda-Lourenco et al.
NEUROBIOLOGY OF DISEASE (2020)
The MeCP2E1/E2-BDNF-miR132Homeostasis Regulatory Network Is Region-Dependent in the Human Brain and Is Impaired in Rett Syndrome Patients
Shervin Pejhan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
DNA Methylation Contributes to the Differential Expression Levels of Mecp2 in Male Mice Neurons and Astrocytes
Vichithra R. B. Liyanage et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases
Dragana Protic et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
1 Simvastatin Induces Apoptosis in Medulloblastoma Brain Tumor Cells via Mevalonate Cascade Prenylation Substrates
Kimia Sheikholeslami et al.
CANCERS (2019)
Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder
Danielle Garfunkel et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2019)
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2
Alexia Martinez de Paz et al.
EPIGENETICS & CHROMATIN (2019)
Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders
Ilse Gantois et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Genome-Wide Transcriptome Landscape of Embryonic Brain-Derived Neural Stem Cells Exposed to Alcohol with Strain-Specific Cross-Examination in BL6 and CD1 Mice
Wayne Xu et al.
SCIENTIFIC REPORTS (2019)
DNA methylation and histone post-translational modification stability in post-mortem brain tissue
Jessica S. Jarmasz et al.
CLINICAL EPIGENETICS (2019)
Rett syndrome: a neurological disorder with metabolic components
Stephanie M. Kyle et al.
OPEN BIOLOGY (2018)
Coral epigenetic responses to nutrient stress: Histone H2A.X phosphorylation dynamics and DNA methylation in the staghorn coral Acropora cervicornis
Javier A. Rodriguez-Casariego et al.
ECOLOGY AND EVOLUTION (2018)
MECP2 Mutation Interrupts Nucleolin-mTOR-P70S6K Signaling in Rett Syndrome Patients
Carl O. Olson et al.
FRONTIERS IN GENETICS (2018)
Visualization of newly synthesized neuronal RNA in vitro and in vivo using click-chemistry
Gueney Akbalik et al.
RNA BIOLOGY (2017)
Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes
Janine M. Lamonica et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Metabolic labeling and recovery of nascent RNA to accurately quantify mRNA stability
Joseph Russo et al.
METHODS (2017)
Metformin ameliorates core deficits in a mouse model of fragile X syndrome
Ilse Gantois et al.
NATURE MEDICINE (2017)
Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
Nikita Katila et al.
NEUROPHARMACOLOGY (2017)
An RNA interference screen identifies druggable regulators of MeCP2 stability
Laura M. Lombardi et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex
Jessica J. Howell et al.
CELL METABOLISM (2017)
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
Ji-chun Zhang et al.
CURRENT NEUROPHARMACOLOGY (2016)
MECP2 Is Post-transcriptionally Regulated during Human Neurodevelopment by Combinatorial Action of RNA-Binding Proteins and miRNAs
Deivid C. Rodrigues et al.
CELL REPORTS (2016)
Ethanol deregulates Mecp2/MeCP2 in differentiating neural stem cells via interplay between 5-methylcytosine and 5-hydroxymethylcytosine at the Mecp2 regulatory elements
Vichithra Rasangi Batuwita Liyanage et al.
EXPERIMENTAL NEUROLOGY (2015)
Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides
Yehezkel Sztainberg et al.
NATURE (2015)
MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells
Ugljesa Djuric et al.
NEUROBIOLOGY OF DISEASE (2015)
MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome
Lin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome
Dag H. Yasui et al.
HUMAN MOLECULAR GENETICS (2014)
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System
Amelia J. McFarland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Rett Syndrome and MeCP2
Vichithra R. B. Liyanage et al.
NEUROMOLECULAR MEDICINE (2014)
NEUROPROTECTIVE EFFECT OF METFORMIN IN MPTP-INDUCED PARKINSON'S DISEASE IN MICE
S. P. Patil et al.
NEUROSCIENCE (2014)
Nucleolar Organization, Ribosomal DNA Array Stability, and Acrocentric Chromosome Integrity Are Linked to Telomere Function
Kaitlin M. Stimpson et al.
PLOS ONE (2014)
Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements
Carl O. Olson et al.
PLOS ONE (2014)
Cholesterol Metabolism Is Altered in Rett Syndrome: A Study on Plasma and Primary Cultured Fibroblasts Derived from Patients
Marco Segatto et al.
PLOS ONE (2014)
Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
Krzysztof Łabuzek et al.
Pharmacological Reports (2014)
Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells
Benjamin A. Barber et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2013)
Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care
Marianne K. DeGorter et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p
Kihoon Han et al.
GENES & DEVELOPMENT (2013)
A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome
Christie M. Buchovecky et al.
NATURE GENETICS (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells
Vichithra R. B. Liyanage et al.
MOLECULAR AUTISM (2013)
A role for metabolism in Rett syndrome pathogenesis New clinical findings and potential treatment targets
Monica J. Justice et al.
RARE DISEASES (2013)
Clinical Outcomes of Downregulation of E-cadherin Gene Expression in Non-small Cell Lung Cancer
Shi-Ying Zheng et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
Jing Wang et al.
CELL STEM CELL (2012)
7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome
Rebecca A. Johnson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2012)
A TrkB Small Molecule Partial Agonist Rescues TrkB Phosphorylation Deficits and Improves Respiratory Function in a Mouse Model of Rett Syndrome
Danielle A. Schmid et al.
JOURNAL OF NEUROSCIENCE (2012)
Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation
M. Uemura et al.
ONCOGENE (2012)
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
Mark L. Wahlqvist et al.
PARKINSONISM & RELATED DISORDERS (2012)
Novel MeCP2 Isoform-Specific Antibody Reveals the Endogenous MeCP2E1 Expression in Murine Brain, Primary Neurons and Astrocytes
Robby M. Zachariah et al.
PLOS ONE (2012)
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
Ruben Deogracias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Giovanni Blandino et al.
NATURE COMMUNICATIONS (2012)
Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
Robby Mathew Zachariah et al.
NEURAL PLASTICITY (2012)
Cholesterol: Its Regulation and Role in Central Nervous System Disorders
Matthias Orth et al.
CHOLESTEROL (2012)
What is a relevant statin concentration in cell experiments claiming pleiotropic effects?
Linda Bjorkhem-Bergman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
Chiara Zuccato et al.
PLOS ONE (2011)
Investigation of Metformin HCl Lot-to-Lot Variation on Flowability Differences Exhibited during Drug Product Processing
Radha R. Vippagunta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Epigenetic Control
Genevieve P. Delcuve et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
Mojgan Rastegar et al.
PLOS ONE (2009)
Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury
Hongtao Wu et al.
JOURNAL OF NEUROTRAUMA (2008)
Exploring RNA transcription and turnover in vivo by using click chemistry
Cindy Y. Jao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome
Michael Ogier et al.
JOURNAL OF NEUROSCIENCE (2007)
Dissecting the human BDNF locus:: Bidirectional transcription, complex splicing, and multiple promoters
Priit Pruunsild et al.
GENOMICS (2007)
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome
GN Mnatzakanian et al.
NATURE GENETICS (2004)
Role of human ribosomal RNA (rRNA) promoter methylation and of Methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression
K Ghoshal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points
S Cooper
FASEB JOURNAL (2003)
The neurotrophin receptor p75NTR:: novel functions and implications for diseases of the nervous system
G Dechant et al.
NATURE NEUROSCIENCE (2002)